The global drug discovery informatics market is poised for a transformational leap, with its valuation projected to grow from USD 16,445.1 million in 2025 to an impressive USD 64,814.3 million by 2035. This projected growth, at a robust CAGR of 14.7%, is being driven by the accelerating adoption of artificial intelligence (AI), machine learning (ML), …
Author Archives: Pranali Shahapurkar
Global COVID-19 Vaccine Packaging and Delivery Devices Market to Reach USD 2,436.1 Million by 2035, Driven by Innovation and Sustainability | FMI
The global market for COVID-19 vaccine packaging and delivery devices is poised for sustained growth, forecasted to expand from USD 1,261.7 million in 2025 to USD 2,436.1 million by 2035, at a CAGR of 6.8%, according to the latest market analysis. The growth is attributed to increasing demand for biopharmaceutical logistics advancements, robust global immunization …
Global Isovaleric Acidemia Treatment Market Set for Remarkable Growth to Reach USD 1,125.15 Million by 2033 at a CAGR of 5.6%
The global isovaleric acidemia treatment market is poised for remarkable growth, projected to rise from USD 652.28 million in 2023 to USD 1,125.15 million by 2033, reflecting a robust CAGR of 5.6%. This expansion is driven by the increasing adoption of advanced technologies and a growing demand for innovative, one-time therapies to address this rare …
Myotonic Dystrophy Treatment Market is projected to Reach USD 2,789.35 Million by 2033 at a CAGR of 12.3% | FMI Report
In 2023, the myotonic dystrophy treatment market is projected to be worth USD 874.39 million. The global demand for myotonic dystrophy treatment is anticipated to increase at a CAGR of 12.3% between 2023 and 2033, reaching a total of around USD 2,789.35 million by 2033 due to the strategic initiatives taken by industry participants and rigorous regulatory environment. A 2020 National Center …
Myelofibrosis (MF) Treatment Market to reach USD 1,280 Million by 2033; Oral Medication to be Primary Approach to Treatment: FMI Report
According to Future Market Insights, myelofibrosis (mf) treatment market is expected to grow at a CAGR of 5.5% between 2023 and 2033, reaching USD 1,280 Million by 2033. The market is expected to reach USD 749.05 Million in 2023, Sales grew at a CAGR of 5.2% from 2018 to 2023. Patients with myelofibrosis can be …
Global Helicobacter Pylori Infections Treatment Market Poised to Reach USD 1,260 Million by 2033 expand at a 7.04% value CAGR | FMI
The global helicobacter pylori infections treatment market is on a robust growth trajectory, with its value projected to escalate from USD 638.3 million in 2023 to an impressive USD 1,260 million by 2033. This expansion, driven by a steady Compound Annual Growth Rate (CAGR) of 7.04%, reflects the growing urgency to address the widespread prevalence …
Global Patient Monitoring Devices Market Set to Soar to USD 125.2 Million by 2032 with a CAGR of 10.5% | Reports FMI
Future Market Insights (FMI) has revealed an insightful new report showcasing the remarkable growth trajectory of the global patient monitoring devices market. Valued at USD 46.4 million in 2022, the market is poised to achieve unprecedented expansion, with projections indicating a staggering valuation of USD 125.2 million by 2032. This equates to a robust Compound …
Global Joint Replacement Market Set to Reach USD 32.2 Billion by 2035 Amid Rising Demand from Aging Population and Degenerative Joint Disorders | FMI
The global joint replacement market is poised for steady growth, with revenue expected to increase from USD 20.3 billion in 2025 to USD 32.2 billion by 2035, rising at a CAGR of 4.7% over the forecast period. This follows an already robust performance in 2024, when global sales were valued at USD 19.4 billion. The …
Rising Demand for Neurological Treatments Fuels Growth in the Multiple System Atrophy Therapeutics Market Projected to Reach USD 211.1 Million by 2033 at a 4.4% CAGR | FMI
The global multiple system atrophy therapeutics market is witnessing steady growth, underpinned by technological advancements, rising awareness of neurodegenerative conditions, and increased healthcare investment. According to a recent market analysis, the market was valued at USD 137.3 million in 2023 and is projected to grow at a Compound Annual Growth Rate (CAGR) of 4.4%, reaching …
Global Alpha-1 Antitrypsin Deficiency Market to Reach USD 10 Billion by 2033 Amid Surge in R&D Investments and Rising Prevalence of Target Illnesses | FMI
According to recent projections by Future Market Insights (FMI), the global alpha-1 antitrypsin deficiency market is poised for significant growth, reaching an estimated USD 10 Billion by 2033, up from USD 3 Billion in 2023. This represents a compound annual growth rate (CAGR) of 12.8% during the forecast period from 2023 to 2033. Alpha-1 Antitrypsin …